Unanticipated toxicity to capecitabine.
Moore
Susan
S
CancerExpertise, Chicago, IL, USA. smoore46@yahoo.com
D001741:Black or African American / Q000235:genetics; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003967:Diarrhea / Q000139:chemically induced; D054067:Dihydropyrimidine Dehydrogenase Deficiency / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics; D016903:Drug Monitoring; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D009730:Nursing Assessment; D009859:Oncology Nursing; D010597:Pharmacogenetics; D012307:Risk Factors; D012449:Safety; D014839:Vomiting / Q000139:chemically induced
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil